Altamir SCA
LTA
Clasificación en acciones
#9664
Altamir SCA, previously known as Altamir Amboise, is a Paris-based private... Altamir SCA, previously known as Altamir Amboise, is a Paris-based private equity firm established in 1995. The company employs a dual investment strategy, engaging in both direct investments and fund-of-funds, primarily targeting small and mid-cap companies. For its direct investments, Altamir concentrates on the middle market, executing buyout and growth capital transactions, and shows a particular interest in acquiring underdeveloped segments of larger corporate entities. When investing through other funds, the firm prioritizes private equity funds that specialize in growth capital and leveraged buyouts, often seeking a majority or lead shareholder position within these investments. Its sector focus is broad, encompassing healthcare, technology (including TMT and digital enterprises), various services, retail and distribution, consumer goods, and business and financial services. Within healthcare, Altamir specifically seeks out high-growth potential companies across health services (such as hospitalization, home care, and medical analysis), medical devices, niche pharmaceutical laboratories, and related areas like dermo-cosmetics, galenic development, and services/databases for health organizations. Geographically, Altamir targets unlisted companies across Europe, with a keen focus on Belgium, France, Luxembourg, Switzerland, Monaco, Italy, the Netherlands, Germany, and French-speaking European regions. It also extends its reach to North America (United States and Canada) and major emerging economies including China, India, and Brazil. For smaller and mid-sized companies, the firm prefers Continental Europe, particularly France, Italy, and the Benelux countries, while larger companies are sought across Europe, North America, and the aforementioned emerging markets. Investment sizes range from an enterprise value of €50 million to €500 million for small to mid-cap entities, and €500 million to €3,000 million for larger enterprises. Altamir makes balance sheet investments and frequently collaborates with Apax Partners France and Amboise Investissement, investing and divesting alongside them under identical terms. Furthermore, it directly invests in funds managed or advised by Apax Partners France and Apax Partners LLC. The firm typically aims for an investment horizon of five years before exiting.
Precio por acción
$25.27
Capitalización bursátil
$921.62M
Cambio (1 día)
-5.32%
Cambio (1 año)
-11.01%
País
FR
Comercio Altamir SCA (LTA)
Categoría
Financial Services
Ratio P/E de Altamir SCA (LTA)
Ratio P/E al 2026 TTM: 0
Según los últimos informes financieros y el precio de las acciones de Altamir SCA, el P/E actual (TTM) de la empresa es 0. Al final de 2026, la empresa tenía un P/E de 0.
Historial del ratio P/E de Altamir SCA desde 2026 hasta 2026
Relación P/E al final de cada año
| Año | Ratio P/E | Cambiar |
|---|---|---|
| Not enough data for the provided dates. | ||
Relación P/E para empresas similares o competidores
| Empresa | P/E Ratio | Diferencia del P/E Ratio | País |
|---|---|---|---|
| 24.09 | - |
US
|
|
| - | - |
SE
|
|
| 23.60 | - |
US
|
|
| 25.48 | - |
US
|
|
| 26.01 | - |
US
|
¿Cómo leer un P/E ratio?
El ratio Precio/Beneficio (P/E Ratio) mide la relación entre el precio de las acciones de una empresa y sus beneficios por acción.
Un P/E bajo pero positivo indica una empresa con altos beneficios en relación a su valoración actual y que podría estar infravalorada. Una empresa con un P/E negativo alto (cerca de 0) indica fuertes pérdidas en comparación con su valoración.
Las empresas con un P/E superior a 30 o negativo suelen considerarse "acciones de crecimiento", lo que significa que los inversores esperan que crezca o se vuelva rentable en el futuro.
Las empresas con un P/E positivo inferior a 10 suelen considerarse "acciones de valor", lo que significa que ya son muy rentables y no se espera un fuerte crecimiento.